Literature DB >> 21908507

Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

K Fizazi1, F A Greco, N Pavlidis, G Pentheroudakis.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21908507     DOI： 10.1093/annonc/mdr389

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  45 in total

Review 1.  Cancer of unknown primary sites: what radiologists need to know and what oncologists want to know.

Authors:  Kyung Won Kim; Katherine M Krajewski; Jyothi P Jagannathan; Mizuki Nishino; Atul B Shinagare; Jason L Hornick; Nikhil H Ramaiya
Journal:  AJR Am J Roentgenol       Date:  2013-03       Impact factor: 3.959

Review 2.  [Importance of nuclear medicine diagnostics in CUP syndrome].

Authors:  M C Winter; U Haberkorn; C Kratochwil
Journal:  Radiologe       Date:  2014-02       Impact factor: 0.635

3.  Survival outcome differences based on treatments used and knowledge of the primary tumour site for patients with cancer of unknown and known primary in Ontario.

Authors:  C S Kim; M B Hannouf; S Sarma; G B Rodrigues; P K Rogan; S M Mahmud; E Winquist; M Brackstone; G S Zaric
Journal:  Curr Oncol       Date:  2018-10-31       Impact factor: 3.677

4.  Comparison of different prostatic markers in lymph node and distant metastases of prostate cancer.

Authors:  Angela Queisser; Susanne A Hagedorn; Martin Braun; Wenzel Vogel; Stefan Duensing; Sven Perner
Journal:  Mod Pathol       Date:  2014-06-13       Impact factor: 7.842

5.  Patients with cancer of unknown primary: a retrospective analysis of 223 patients with adenocarcinoma or undifferentiated carcinoma.

Authors:  Harald Löffler; Joe Puthenparambil; Thomas Hielscher; Kai Neben; Alwin Krämer
Journal:  Dtsch Arztebl Int       Date:  2014-07-07       Impact factor: 5.594

6.  A prospective comparison of 18F-FDG PET/CT and CT as diagnostic tools to identify the primary tumor site in patients with extracervical carcinoma of unknown primary site.

Authors:  Anne Kirstine H Møller; Annika Loft; Anne K Berthelsen; Karen D Pedersen; Jesper Graff; Charlotte B Christensen; Junia C Costa; Lene T Skovgaard; Katharina Perell; Bodil L Petersen; Gedske Daugaard
Journal:  Oncologist       Date:  2012-06-18

7.  [Structured diagnostics and therapy of the CUP syndrome].

Authors:  H Löffler; K Neben; A Krämer
Journal:  Radiologe       Date:  2014-02       Impact factor: 0.635

8.  Mutational profiling of the RAS, PI3K, MET and b-catenin pathways in cancer of unknown primary: a retrospective study of the Hellenic Cooperative Oncology Group.

Authors:  G Pentheroudakis; E A Kotteas; V Kotoula; K Papadopoulou; E Charalambous; A Cervantes; T Ciuleanu; G Fountzilas; N Pavlidis
Journal:  Clin Exp Metastasis       Date:  2014-07-05       Impact factor: 5.150

Review 9.  Lung Cancer Detected 5 Years after Resection of Cancer of Unknown Primary in a Mediastinal Lymph Node: A Case Report and Review of Relevant Cases from the Literature.

Authors:  Hidenori Kawasaki; Kazunari Arakaki; Naohiro Taira; Tomonori Furugen; Takaharu Ichi; Tomofumi Yohena; Tsutomu Kawabata
Journal:  Ann Thorac Cardiovasc Surg       Date:  2015-09-02       Impact factor: 1.520

10.  Global microRNA profiling in favorable prognosis subgroups of cancer of unknown primary (CUP) demonstrates no significant expression differences with metastases of matched known primary tumors.

Authors:  George Pentheroudakis; Yael Spector; Dimitrios Krikelis; Vassiliki Kotoula; Eti Meiri; Vassiliki Malamou-Mitsi; George Fountzilas; Mats Sanden; Nicholas Pavlidis; Hila Benjamin; Ranit Aharonov
Journal:  Clin Exp Metastasis       Date:  2012-11-04       Impact factor: 5.150
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.